SCHEMBL28206342

SCHEMBL28206342

COC(=O)c1cccc(CNCCO)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 3/20 0.68
CYP4A11 Q02928 3/20 0.68
LOXL2 Q9Y4K0 1/20 0.60
HIF1A Q16665 1/20 0.56
SLC7A5 Q01650 1/20 0.56
SENP1 Q9P0U3 1/20 0.49
FOLH1 Q04609 1/20 0.49
MRGPRX4 Q96LA9 2/20 0.49
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 1/20 0.48
MAPT P10636 1/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
PDCD1 Q15116 1/20 0.47
CD274 Q9NZQ7 1/20 0.47
HPGD P15428 1/20 0.46
ROCK2 O75116 1/20 0.46
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21579366 0.89 LOXL2 (0.70) CYP4F2CYP4A11LOXL2HIF1ASLC7A5
SCHEMBL16355834 0.86 SLC7A5 (0.57) CYP4F2CYP4A11LOXL2HIF1ASLC7A5
SCHEMBL21089603 0.85 HIF1A (0.61) CYP4F2CYP4A11LOXL2HIF1ASLC7A5
SCHEMBL308038 0.84 LOXL2 (0.64) CYP4F2CYP4A11LOXL2HIF1ASLC7A5
SCHEMBL14143797 0.84 LOXL2 (0.64) CYP4F2CYP4A11LOXL2HIF1ASLC7A5
SCHEMBL14793785 0.83 MEP1B (0.63) HIF1AFOLH1MRGPRX4PDCD1CD274
SCHEMBL11846611 0.82 CYP4F2 (0.64) CYP4F2CYP4A11LOXL2HIF1ASLC7A5
Hydrochloric Acid SCHEMBL11854001 0.81 CYP4F2 (0.62) CYP4F2CYP4A11LOXL2HIF1ASLC7A5
SCHEMBL45633 0.81 LOXL2 (0.68) CYP4F2CYP4A11LOXL2HIF1ASLC7A5
SCHEMBL28206352 0.81 CYP4A11 (0.60) CYP4F2CYP4A11LOXL2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107873023-A 3-alkyl-4-amido-bicyclo [4, 5, 0] hydroxamic acids as HDAC inhibitors 福马治疗股份有限公司 2018-04-03 CN disclosed